Propranolol Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Propranolol Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Oct 31, 2023. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9872-10
Dosage Form
Injection
Presentation
Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)
Initial Posting
Oct 31, 2023

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.